Tech companies are investing time and money into products that will keep consumers begging for more. » Read More
Alex Tarrant, assistant editor at Dealreporter Europe, Mergermarket Group, shares his views on the deal between Pfizer and Medivation. » Read More
Pfizer investors should be concerned about the high premium, while Medivation investors should celebrate, says RBC Capital Markets' Simos Simeonidis.
CNBC's Meg Tirrell reports on the action in the IBB biotech ETF after Pfizer announced it was buying Medivation and what some other big M&A deals could be coming down the line. The "Fast Money" traders weigh in.
CNBC's Meg Tirrell reports the details on Pfizer's deal for Medivation.
Biotech stocks have underperformed the market but that could change as investors bet more deals could be in the making.
Boutique banks are taking more deal flow from the biggest firms on the Street.
The acquisition will give Pfizer access to Medivation's successful cancer treatments under development.
Alimentation Couche-Tard said it would buy CST Brands for about $3.67 billion, as the company looks to strengthen its U.S. operations.
Medivation surged more than 19 percent Monday after Pfizer said it would buy the cancer drug company for about $14 billion.
Drugmaker Pfizer expects the deal to add $0.05 to EPS in the first year, reports CNBC's Meg Tirrell.
Pfizer is reportedly near a deal to acquire cancer drug company Medivation for approximately $14 billion, reports CNBC's Meg Tirrell.
Pfizer is in advanced talks to acquire Medivation for close to $14 billion, as it seeks to boost its oncology portfolio.
Liverpool Football Club's owners haven't received a bid, a club source said on Sunday, after reports of interest from a Chinese-led consortium.
CNBC's Susan Li looks ahead to what are likely to be next week's top business and financial stories.
Investment banking in Europe is down, as Wall Street firms expand their presence overseas.
Emerson Electric said it would buy pump manufacturer Pentair's valves & controls business for $3.15 billion in cash, as it expand its core businesses.
American Apparel has hired investment bank Houlihan Lokey to explore a sale, people familiar with the matter said on Wednesday.
Get the best of CNBC in your inbox